Sensus Healthcare announces that Samuel O’Rear will not stand for reelection to the Company’s Board of Directors at the Company’s 2024 annual meeting of stockholders. O’Rear has been a Director of Sensus Healthcare since 2012. As previously announced, on January 11, 2024 the Board of Directors of Sensus Healthcare appointed Michael Sardano, President and General Counsel of Sensus Healthcare, as a Director, effective today.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SRTS:
- Sensus Healthcare Announces Retirement of Director Samuel O’Rear
- Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024
- Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million
- Sensus Healthcare sees Q4 revenue over $12M, consensus $7.52M
